INNOVATIVE PHAR issued 148.5 million shares based on the exercise of the conversion rights of convertible bonds

智通財經
2025.07.31 15:04

智通財經 APP 訊，領航醫藥生物科技發佈公告，根據行使於 2013 年 10 月 25 日發行的可換股債券的轉換權而於 2025 年 7 月 31 日發行換股股份 1.485 億股。

智通財經 APP 訊，領航醫藥生物科技 (00399) 發佈公告，根據行使於 2013 年 10 月 25 日發行的可換股債券的轉換權而於 2025 年 7 月 31 日發行換股股份 1.485 億股。

Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.